WHO suspends clinical trial of hydroxychloroquine for COVID-19

Published on May 25, 2020 by

The World Health Organization has suspended a clinical trial of anti-malaria drug hydroxychloroquine for COVID-19 treatment.
It has cited safety concerns.
US President Donald Trump said recently he was taking the drug but has since stopped.
The WHO and health authorities around the world have warned of the drug’s potentially dangerous side effects.
There is also no definitive proof that it is effective against the coronavirus.

0 0 votes
Article Rating
Category Tag
0 0 votes
Article Rating
Notify of
Inline Feedbacks
View all comments